|
|
||||||||
American Journal of Clinical Nutrition, Vol 53, 1112-1116, Copyright © 1991 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
HL Barlett, SM Puhl, JL Hodgson and ER Buskirk
Noll Laboratory for Human Performance Research, College of Health and Human Development, Pennsylvania State University, University Park 16802.
A cross-sectional relationship of fat-free mass to height expressed as a ratio (FFM:ht) is presented for 1103 people aged 6-86 y. Data are presented for 13 specific age groups by gender. By providing information for normal, healthy individuals, these data may be of comparative value for nutritionists and clinicians concerned with body composition of patients with wasting diseases. The data were collected over 20 y in our laboratory by using the same densitometric procedure. A significant increase in FFM:ht occurs during the preadolescent and adolescent years. The adolescent spurt continues for a longer period for boys than for girls, resulting in a significant gender difference beginning at approximately age 16 y and continuing throughout adulthood. A decline in FFM:ht, not statistically significant, appears to occur in men greater than 60 y of age, and a significant decline occurs among women greater than 50 y of age (alpha less than 0.01). Thus, both gender- and age-related trends that have implications for the interpretation of comparative body-composition status are suggested.
This article has been cited by other articles:
![]() |
P T Williams Association between walking distance and percentiles of body mass index in older and younger men Br. J. Sports Med., May 1, 2008; 42(5): 352 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Attanasio, E. Shavrikova, W. F. Blum, M. Cromer, C. J. Child, M. Paskova, J. Lebl, J. J. Chipman, the Hypopituitary Developmental Outcome Study Grou, and S. M. Shalet Continued Growth Hormone (GH) Treatment after Final Height Is Necessary to Complete Somatic Development in Childhood-Onset GH-Deficient Patients J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4857 - 4862. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kajantie, C. H. D. Fall, M. Seppala, R. Koistinen, L. Dunkel, H. Yliharsila, C. Osmond, S. Andersson, D. J. P. Barker, T. Forsen, et al. Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-1 in Elderly People: Relationships with Cardiovascular Risk Factors, Body Composition, Size at Birth, and Childhood Growth J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Attanasio, S. Howell, P. C. Bates, P. Frewer, J. Chipman, W. F. Blum, and S. M. Shalet Body Composition, IGF-I and IGFBP-3 Concentrations as Outcome Measures in Severely GH-Deficient (GHD) Patients after Childhood GH Treatment: A Comparison with Adult Onset GHD Patients J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3368 - 3372. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Palmieri, G. de Simone, M. J. Roman, J. E. Schwartz, T. G. Pickering, and R. B. Devereux Ambulatory Blood Pressure and M;etabolic Abnormalities in Hypertensive Subjects With Inappropriately High Left Ventricular Mass Hypertension, November 1, 1999; 34(5): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |